At a glance
- Originator Pfizer
- Class Pyridines; Small molecules; Sulfonamides
- Mechanism of Action Alpha 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia
Most Recent Events
- 11 Apr 2002 Phase-II clinical trials in Benign prostatic hyperplasia in United Kingdom (unspecified route)